<DOC>
	<DOCNO>NCT01216397</DOCNO>
	<brief_summary>The objective current study investigate relative bioavailability two different batch 2.5 mg linagliptin / 1000 mg metformin fix dose combination tablet ( FDC ) .</brief_summary>
	<brief_title>Relative Bioavailability Two Different Batches Linagliptin / Metformin Combination Tablet Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Linagliptin</mesh_term>
	<criteria>Inclusion criterion : 1 . Healthy male female accord follow criterion : Based upon complete medical history , include physical examination , vital sign ( blood pressure ( BP ) , pulse rate ( PR ) ) , 12lead electrocardiogram ( ECG ) , clinical laboratory test 2 . Age 21 50 year ( incl . ) 3 . Body Mass Index ( BMI ) 18.5 29.9 kg/m2 ( incl . ) 4 . Signed date write informed consent prior admission study accordance Good Clinical Practice ( GCP ) local legislation Exclusion criterion : 1 . Any finding medical examination ( include BP , PR ECG ) deviate normal clinical relevance 2 . Any evidence clinically relevant concomitant disease 3 . Gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder 4 . Surgery gastrointestinal tract ( except appendectomy ) 5 . Diseases central nervous system ( epilepsy ) psychiatric disorder neurological disorder 6 . History relevant orthostatic hypotension , faint spell blackouts 7 . Chronic relevant acute infection 8 . History relevant allergy hypersensitivity ( include allergy drug excipients ) 9 . Intake drug within one month le 10 halflives respective drug prior first study drug administration 10 . Participation another trial investigational drug within 2 month prior administration trial 11 . Smoker ( 10 cigarette 3 cigar 3 pipe daily ) 12 . Alcohol abuse ( average consumption 20 g/day female 30 g/day male ) 13 . Drug abuse 14 . Blood donation ( 100 mL within four week prior day 1 visit 2 ) 15 . Any laboratory value outside reference range clinical relevance 16 . Inability comply dietary regimen trial site For female subject childbearing potential : 17 . Positive pregnancy test , pregnancy plan become pregnant 1 month study within 2 month study completion 18 . No adequate contraception 1 month study 2 month study completion , e.g . follow : implant , injectables , combine hormonal contraceptive , hormonal IUD ( intrauterine device ) , sexual abstinence least 1 month prior first study drug administration , vasectomise partner ( vasectomy perform least 1 year prior enrolment ) , surgical sterilisation ( include hysterectomy ) . Females , vasectomise partner , sexually abstinent surgically sterile ask use additional barrier method ( e.g . condom ) . 19 . Lactation</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>February 2014</verification_date>
</DOC>